Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05606432 · ClinicalTrials.gov registry record · NA
Cardiometabolic Health Intervention Using Movement-to-Music Exercise
A NA study of Cardiometabolic Risk Factors in Adult Wheelchair Users, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- NA
- Development phase
- 132
- Enrollment target
- 1
- Study location
NCT05606432: Recruiting NA study of Cardiometabolic Risk Factors in Adult Wheelchair Users, sponsored by University of Alabama at Birmingham.
NCT05606432 is a NA study of Cardiometabolic Risk Factors in Adult Wheelchair Users that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 132 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05606432, a NA study of Cardiometabolic Risk Factors in Adult Wheelchair Users, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- NA
- Development phase
- 132 participants
- Enrollment target
- 1
- Study location
Study Summary
The study aims to test the benefits of a 24-week, cardio-emphasized Movement-to-Music exercise program for reversing cardiometabolic health risk factors compared to asynchronous, standard exercise programs among 132 adult wheelchair users. The targeted cardiometabolic health factors are waist circumference, triglycerides, "good" cholesterol, glucose, and blood pressure. Additionally, a 12-week follow-up phase (weeks 25-36) is included to see whether the gains are maintained.
Primary Outcome
Blood test Sphygmomanometer
Conditions Studied
Interventions
- OTHER Instructor-led, one-on-one M2M exercise group
- OTHER Self-guided control with pre-recorded standard exercise videos
Study Locations (1)
Alabama
- The University of Alabama at Birmingahm - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2023-09-11 |
| Est. Completion | 2027-12-30 |
| Phase | NA |
What NCT05606432 shows while recruiting
NCT05606432 is an interventional study that assigns participants to a tested intervention. The registered 132 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Cardiometabolic Risk Factors in Adult Wheelchair Users appearing as the primary indexed condition, and to 2 interventions - of which Instructor-led, one-on-one M2M exercise group is the first listed.
NCT05606432 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT05606432 about?
NCT05606432 is a clinical study titled "Cardiometabolic Health Intervention Using Movement-to-Music Exercise". The study aims to test the benefits of a 24-week, cardio-emphasized Movement-to-Music exercise program for reversing cardiometabolic health risk factors compared to asynchronous, standard exercise programs among 132 adult wheelchair users. The targeted cardiometabolic health factors are waist circum...
What is the current status of trial NCT05606432?
This trial is currently recruiting. It is a NA study. The enrollment target is 132 participants. The study started on 2023-09-11. Estimated completion is 2027-12-30.
What conditions does trial NCT05606432 study?
This clinical trial studies the following conditions: Cardiometabolic Risk Factors in Adult Wheelchair Users.
What interventions are being tested in trial NCT05606432?
The interventions under investigation include: Instructor-led, one-on-one M2M exercise group (OTHER), Self-guided control with pre-recorded standard exercise videos (OTHER).
Who is sponsoring clinical trial NCT05606432?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05606432 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05606432's enrollment target sits among peer trials
132 729th of 2000 higher than 1,269 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01766297 · 132 participants · Phase 2
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
- NCT04002947 · 132 participants · Phase 2
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
- NCT04128189 · 132 participants · Phase 3
Shingrix in Renal Transplant Recipients
- NCT04199780 · 132 participants · NA
Effects of tDCS Combined With CBI on Postsurgical Pain
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI